Category Archives: Legal

Patients Want to Talk. Do You?

Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law. It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Also posted in E-Media, Europe, FDA, Global, Guest Blog | Tagged , , , , , | 1 Comment

Mass Gift Ban Repeal Efforts Fizzle

An effort in the Massachusetts legislature to repeal the state’s ban on many gifts to healthcare providers has failed. The year-old ban is considered one of the most restrictive in the country, banning restaurant meals, various gifts and requiring reporting on transfers of value above $50. “This repeal effort was started by legislators concerned that the [...]
Posted in Legal | Tagged , , , , , , , | Leave a comment

Avandia on Trial

The mid-July FDA advisory committee meeting to decide the fate of GlaxoSmithKline’s Avandia (rosiglitazone) is widely viewed as a test case of how the agency’s new leadership will address controversial drugs with serious risks but confusing data. A request that GSK yank its diabetes blockbuster—three years after first being associated with an increased risk of [...]
Posted in Legal | Tagged , , , , , , , | Leave a comment

AZ Celebrates Crestor Patent Win

The US District Court in Delaware upheld AstraZeneca’s patent for its blockbuster statin Crestor (rosuvastatin), ending a dispute that could have crippled the drugmaker’s billion-dollar cash cow. Crestor’s patent is not scheduled to expire until 2016. However, a group of generics firms had claimed that a substance patent (314) protecting one of the active ingredients in [...]
Posted in Legal | Tagged , , , , , , , | Leave a comment

Government Crackdown on the C-Suite

Over the past decade, the drug industry has paid tens of billions of dollars to settle state and federal lawsuits involving the False Claims Act—defrauding Medicare and Medicaid, promoting drugs for unapproved uses, paying kickbacks to doctors and pharmacies, and the like. Stories about off-label promotion of drugs with serious adverse effects and no proven [...]
Posted in Legal | Tagged , , , , , | Leave a comment